Biogen (BIIB) Other Operating Expenses (2009 - 2026)

Biogen's Other Operating Expenses history runs 18 years deep, the most recent figure standing at -$19.7 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 71.2% year-over-year to -$19.7 million; the TTM figure through Mar 2026 stood at -$53.8 million (down 2141.67% YoY), while the FY2024 annual figure was -$27.7 million, changed N/A from the prior year.
• Other Operating Expenses was -$19.7 million for Q1 2026 at Biogen, up from -$34.1 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $428.6 million in Q2 2022 to a low of -$300.0 million in Q3 2023.
• Historically, Other Operating Expenses has averaged $5.8 million across 5 years, with a median of -$17.2 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Other Operating Expenses surged 344.61% in 2022, then slumped 1077.46% in 2023.
• A 5-year view of Other Operating Expenses shows it stood at -$12.2 million in 2022, then sank by 2359.02% to -$300.0 million in 2023, then jumped by 155.33% to $166.0 million in 2024, then sank by 120.54% to -$34.1 million in 2025, then jumped by 42.23% to -$19.7 million in 2026.
• The last three Other Operating Expenses figures came in at -$19.7 million (Q1 2026), -$34.1 million (Q3 2025), and -$68.4 million (Q1 2025), per Business Quant data.